Ova-Mit Special Precautions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Special Precautions

Before starting treatment with Clomifene Citrate (Ova-Mit), the patient should be thoroughly examined to exclude liver disease, pituitary or ovarian failure and neoplasms of the endometrium. The cause of infertility and any abnormal bleeding should be investigated. The patients should be warned by the possibility of multiple births. Prolonged courses of treatment are not recommended. Patients should be warned that visual symptoms may occasionally occur during treatment.

clomifene

Manufacturer:

Remedica

Distributor:

Corbridge